Journal Overview: Transplantation and Cellular Therapy
Transplantation and Cellular Therapy is the official publication of the American Society for Transplantation and Cellular Therapy (ASTCT). Formerly known as “Biology of Blood and Marrow Transplantation,” the journal has achieved a significant Impact Factor of 5.609 in 2021, reflecting its stature in the field.
Key features and focus areas of Transplantation and Cellular Therapy include:
1. Interdisciplinary Field: The journal is dedicated to covering the interdisciplinary field of hematopoietic stem cell transplantation (HSCT) and the expanding realm of both transplant and non-transplant cellular immunotherapies. It serves as a valuable resource for professionals involved in these areas.
2. Content Variety: Transplantation and Cellular Therapy publishes a wide range of content, including original research reports, practice guidelines, comprehensive reviews, editorials, commentaries, and letters to the editor. This diversity of content provides readers with access to the latest research findings, expert insights, and clinical guidance.
3. Official Publication: As the official publication of ASTCT, the journal is positioned at the forefront of disseminating cutting-edge research and advancements in the field of cellular therapies. It serves as a platform for sharing knowledge and promoting excellence in transplantation and cellular therapy.
Transplantation and Cellular Therapy is committed to providing a platform for the exchange of scientific knowledge and the dissemination of research findings in the English language. It plays a pivotal role in advancing the understanding and practice of hematopoietic stem cell transplantation and cellular immunotherapies.
Healthcare professionals, researchers, and practitioners interested in the latest developments in these fields can benefit from the insights and information offered by this journal.